SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals enters into partnership to develop dialysis system in India

10 Oct 2013 Evaluate

Apollo Hospitals Enterprise has entered into collaboration with Medtronic, Inc., the global leader in medical technology, to bring to market an innovative, affordable and portable hemodialysis system in India. This would help improve access to care for End Stage Renal Disease (ESRD) patients who need Renal Replacement Therapy (RRT). 

This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo envisioning a cost reduction by 10-20 per cent for patients. At present, on an average a patient spends about Rs 1,200 to Rs 2,000 for a dialysis.

Medtronic intends to develop and manufacture key components of this hemodialysis system in India which will be ready for commercial launch in 2016.

Apollo Hospital Ent. Share Price

7699.05 143.10 (1.89%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×